Skip to content

In the BioHarmony Drug Report Database


Alamast (pemirolast) is a small molecule pharmaceutical. Pemirolast was first approved as Alamast on 1999-09-24. It is used to treat allergic conjunctivitis in the USA.
Trade Name Alamast
Common Name Pemirolast
Indication allergic conjunctivitis
Drug Class Antiasthmatics/antiallergics (not acting primarily as antihistamines)
Get full access now